Gene5877
RABIF: RAB interacting factor
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. RABIF: RAB interacting factor. Genes, record 5877. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/5877
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P47224 | Guanine nucleotide exchange factor MSS4 | 123 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents52
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 60612 | P47224 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8192 | P47224 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 8192 | P47224 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8192 | P47224 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 9299 | P47224 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 9299 | P47224 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 32757 | P47224 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 60612 | P47224 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 132942 | P47224 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 70521 | P47224 | Espacenet |
NIH grants140
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RABIF papers | Newest fiscal year |
|---|---|---|---|
| R01HL164409 | High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux | 2 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 1 | 2025 |
| P30CA016359 | Cancer Center Support Grant | 1 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 1 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 1 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 1 | 2025 |
| P30DK036836 | Diabetes Research Center | 1 | 2025 |
| P30ES006694 | Southwest Environmental Health Sciences Center | 1 | 2025 |
| P30ES007048 | Environmental Exposures, Host Factors and Human Disease | 1 | 2025 |
| P30ES023515 | Mount Sinai Center for Health and Environment Across the LifeSpan (HEALS) | 1 | 2025 |
Source NIH's project files
Papers164
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning analysis of coagulation-related genes for breast cancer diagnosis and prognosis prediction. | Sci Rep | 2025 | 41073559 | PubTator, text mining | PubMed |
| CRISPR-Cas9 screening identified novel subtypes of cutaneous melanoma based on essential cancer genes. | Arch Dermatol Res | 2024 | 39644349 | PubTator, text mining | PubMed |
Correction: Huang et al. Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer. Cells 2021, 10, 2524. | Cells | 2024 | 39594676 | PubTator, text mining | PubMed |
| RABIF promotes hepatocellular carcinoma progression through regulation of mitophagy and glycolysis. | Commun Biol | 2024 | 39414994 | PubTator, text mining | PubMed |
| Dynamic proximity interaction profiling suggests that YPEL2 is involved in cellular stress surveillance. | Protein Sci | 2024 | 38145972 | PubTator, text mining | PubMed |
| Identification of the Roles of Coagulation-related Signature and its Key Factor RABIF in Hepatoma Cell Malignancy. | Recent Pat Anticancer Drug Discov | 2024 | 37644748 | PubTator, text mining | PubMed |
| Sphingomyelin synthase 1 supports two steps of rubella virus life cycle. | iScience | 2023 | 38026182 | PubTator, text mining | PubMed |
| A CRISPR Screen Identifies the E3 Ubiquitin Ligase Rfwd2 as a Negative Regulator of Glucose Uptake in Brown Adipocytes. | Genes (Basel) | 2023 | 37895214 | PubTator, text mining | PubMed |
| Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy. | Cancer Drug Resist | 2023 | 37842235 | PubTator, text mining | PubMed |
| Identification of a coagulation-related signature correlated with immune infiltration and their prognostic implications in lung adenocarcinoma. | Thorac Cancer | 2023 | 37795779 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/5877
GET https://conductscience.org/api/genes/v1/5877/patents?page=2